Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Haemopharm
Milan, Lombardy, Italyhaemopharm.it ↗
- Ownership
- Private
- Employees
- ~6
- Development stage
- Other
01
Overview
Haemopharm has established itself as a leader in the infusion sector, specializing in the design, development, and manufacture of flexible IV bags and advanced drug delivery systems. Their portfolio includes patented technologies such as SAFE2® cryopreservation bags. They serve global pharmaceutical, biotech, hospital pharmacy, and specialty care markets with both standard and highly customized solutions. No clinical trial results apply as they do not develop drugs but supply medical devices/packaging.
- Therapeutic areas
- NephrologyOphthalmologyMetabolic DisordersOther
- Modalities
- Device (IV bags, drug delivery systems, cryopreservation bags)Biologic (as containers for cell therapy products)Small molecule (as containers for sterile solutions and drugs)
- Industry
- Consumable Medical Devices
02
Partnerships
Medigas Italia (formerly SIAD Healthcare) – co-development of stem cell/tissue cryopreservation systems.Various international pharma/device companies via contract manufacturing agreements.
Beyond the preview
Go deeper on Haemopharm.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Haemopharm.